Reneo Pharma Ltd   Report issue

For profit Phase 3
Founded: San Diego CA United States (2018)

Organization Overview

First Clinical Trial
2019
NCT03833128
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Reneo Pharma Ltd